CALQUENCE® (acalabrutinib) Patient Management & Adherence – Bradley, NP Published 2024-01-04 Download video MP4 360p Download video MP4 720p Recommendations 2:04:16 Living with Chronic Lymphocytic Leukemia (CLL): A CALQUENCE™ Connections Virtual Event 1:09:24 Chronic Lymphocytic Leukemia During COVID: A Patient Story 16:53 CALQUENCE® (acalabrutinib) Pooled CV Safety Analysis – Dr Pinilla-Ibarz, MD 18:34 CALQUENCE® (acalabrutinib) ELEVATE-RR and ASCEND Data – Dr Ma, MD 18:07 CALQUENCE® (acalabrutinib) ACE-CL-001 (ibrutinib-intolerant cohort) – Dr Raval, MD 05:49 CALQUENCE (acalabrutinib) Patient Testimonials: Wendy's Story 14:51 CALQUENCE® (acalabrutinib) ELEVATE-TN, incl. High-Risk Subgroups – Dr Abutalib, MD 11:41 CALQUENCE® (acalabrutinib) Safety Data – Dr Levy, MD 19:34 CALQUENCE® (acalabrutinib) R/R CLL MAIC of ASCEND and ALPINE – Dr Skarbnik, MD 11:54 CALQUENCE® (acalabrutinib) Perspectives: Dr Alexey Danilov, MD, PhD 11:56 CALQUENCE® (acalabrutinib) Mechanism of Action (MOA) – Dr Pearson, MD 03:11 CALQUENCE (acalabrutinib) Patient Testimonials: Steve's Story 10:56 CALQUENCE® (acalabrutinib) Perspectives: Dr Tara Graff, DO 04:44 CALQUENCE (acalabrutinib) Patient Testimonials: Emil's Story 02:10 How CALQUENCE® (acalabrutinib) Works 08:57 CALQUENCE® (acalabrutinib) Perspectives: Dr Andre Goy, MD 08:28 Sharon's Treatment Story 03:30 Dan’s Story: Living with CLL 04:06 CALQUENCE® (acalabrutinib) Patient Testimonials: Jim’s Story 01:01 Focus on the Things You're Loving